Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193. (29th June 2018)

• Record Type: Journal Article
• Authors: Tchesnokova, Veronika L; Rechkina, Elena; Larson, Lydia; Ferrier, Kendra; Weaver, Jamie Lee; Schroeder, David W; She, Rosemary; Butler-Wu, Susan M; Aguero-Rosenfeld, Maria E; Zerr, Danielle; Fang, Ferric C; Ralston, James; Riddell, Kim; Scholes, Delia; Weissman, Scott; Parker, Kaveri; Spellberg, Brad; Johnson, James R; Sokurenko, Evgeni V
• Is Part Of: Clinical infectious diseases. Volume 68:Number 2(2019)
• Page Start: 334
• Page End: 337
• Publication Date: 2018-06-29
• Subjects: urinary tract infections -- Escherichia coli -- fluoroquinolone resistance; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciy525
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: We describe the rapid and ongoing emergence across multiple US cities of a new multidrug-resistant Escherichia coli clone—sequence type (ST) 1193—resistant to fluoroquinolones (100%), trimethoprim-sulfamethoxazole (55%), and tetracycline (53%). ST1193 is associated with younger adults (age <40 years) and currently comprises a quarter of fluoroquinolone-resistant clinical E. coli urine isolates.